1. Home
  2. PKX vs GH Comparison

PKX vs GH Comparison

Compare PKX & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POSCO Holdings Inc.

PKX

POSCO Holdings Inc.

N/A

Current Price

$59.68

Market Cap

18.0B

Sector

Industrials

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$90.46

Market Cap

13.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKX
GH
Founded
1968
2011
Country
South Korea
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0B
13.3B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
PKX
GH
Price
$59.68
$90.46
Analyst Decision
Strong Buy
Analyst Count
0
20
Target Price
N/A
$117.80
AVG Volume (30 Days)
158.1K
1.6M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$5.89
$33.40
Revenue Next Year
$3.90
$28.55
P/E Ratio
$42.95
N/A
Revenue Growth
N/A
32.88
52 Week Low
$40.80
$36.36
52 Week High
$71.35
$120.74

Technical Indicators

Market Signals
Indicator
PKX
GH
Relative Strength Index (RSI) 39.80 34.26
Support Level $58.83 $89.32
Resistance Level $61.24 $114.53
Average True Range (ATR) 1.90 5.32
MACD -1.34 -0.60
Stochastic Oscillator 15.49 10.09

Price Performance

Historical Comparison
PKX
GH

About PKX POSCO Holdings Inc.

POSCO Holdings Inc is a holding company and operates through its subsidiaries. The company operates across four distinct segments. The first segment is the Steel Segment, which includes the production and sale of steel products. The second segment is the Infrastructure Business, which is further divided into three operations. The Trading Segment comprises trading and natural resource development activities. The Construction Segment involves the planning, designing, and construction of industrial plants, civil engineering projects, and buildings. The Logistics and Others Segment. The third segment is the Secondary Battery Materials Segment, and the fourth segment is the Others Segment.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: